Article
CD39 polymorphism enables lung thrombosis in sickle cell disease.
Nature communications - 14 Jan 2026
Brzoska Tomasz, Kaminski Tomasz W, Katoch Omika, Menchikova Elizaveta V, Alagbe Adekunle E, Tashbook Sarah E, Tofovic Stevan P, Jonassaint Jude C, St Croix Claudette M, Watkins Simon C, Howe Shane, Field Joshua J, Seyerle Amanda A, Pradhan-Sundd Tirthadipa, Laurie Cecilia, Pankratz Nathan D, Smith Nicholas L, Goode Ellen L, Pankow James S, Kooperberg Charles, Kato Gregory J, Zhang Yingze, Novelli Enrico M, Gladwin Mark T, Jackson Edwin K, Nouraie Seyed M, Sundd Prithu
Abstract excerpt
Sickle cell disease (SCD) is the most common monogenic-hemolytic disorder affecting people of African ancestry. Adenosine diphosphate (ADP) released following intravascular hemolysis activates platelets by stimulating purinergic receptors to promote thrombosis. Despite brisk intravascular hemolysis, which releases high levels of ADP into plasma, and evidence of platelet and hemostatic activation, it remains...
Topics
Join the communities discussing this publication.
